copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Our leadership team - Bristol Myers Squibb Meet the executive leaders at Bristol Myers Squibb who are not only responsible for day-to-day operations, but are also innovators in the biotech industry committed to patients, customers, employees, community and stockholders
Bristol Myers Squibb Announces Leadership Transition Plan Giovanni Caforio, MD, Bristol Myers Squibb Chairman and CEO, to Retire as CEO, Effective November 1, 2023; Will Continue as Executive Chairman of the Board Christopher Boerner, PhD, EVP, Chief Commercialization Officer, Appointed EVP, Chief Operating Officer, Effective Immediately; to Succeed Giovanni Caforio, MD, as CEO, Effective November 1, 2023 Adam Lenkowsky Appointed EVP, Chief
Bristol Myers Squibb’s Post - LinkedIn Today Chris Boerner begins his new role as our CEO and on April 1, 2024, he’ll succeed Giovanni Caforio as Chair of the Board of Directors With over eight years’ experience at BMS leading
Bristol Myers Squibb CEO Christopher Boerner outlines plans Christopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last November, and immediately made a big move: a series of three acquisitions totaling $24 billion that
Christopher Boerner, CEO of Bristol-Myers Squibb Christopher Boerner is the new CEO of Bristol Myers Squibb, stepping into his role on November 1, 2023 Before this, he held various important positions within the company since joining in 2015, showing a steady rise through roles like Chief Commercialization Officer and Head of International Markets
Bristol Myers Squibb CEO and Key Executive Team - Craft. co Bristol Myers Squibb's Chief Executive Officer and Director is Chris Boerner Other executives include Sandra Leung, Executive Vice President, General Counsel; David Elkins, Executive Vice President and Chief Financial Officer and 47 others See the full leadership team at Craft
Bristol-Myers CEO awarded $19M after a difficult year Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the pharmaceutical company The New Jersey-based company posted a net loss of $8
Bristol Myers Squibb Appoints Christopher Boerner as Chief Executive . . . Bristol Myers Squibb announced that Christopher Boerner, Ph D , as of November 1, Boerner will be Chief Executive Officer of Bristol Myers Squibb About Christopher Boerner, Ph D : Christopher Boerner has served as EVP, Chief Operating Officer and CEO-elect since April 26, 2023 He was appointed EVP, Chief Commercialization Officer on August 28, 2018, where he led the worldwide Commercial and